Research Article
The Value of Safflower Yellow Injection for the Treatment of Acute Cerebral Infarction: A Randomized Controlled Trial
Table 2
Comparison of hemorheological index before and after treatment between 2 groups (
).
| Variables | Control group | Safflower Yellow Injection group | = 31 | = 66 | Pretreatment | Posttreatment | Pretreatment | Posttreatment |
| Whole blood viscosity (mPa·s/150 s−1) | 5.95 ± 0.80 | 5.34 ± 0.83# | 5.92 ± 0.82 | 5.14 ± 0.85*# | Whole blood viscosity (mPa·s/5 s−1) | 12.66 ± 2.52 | 12.57 ± 2.24 | 12.69 ± 2.64 | 10.05 ± 2.48*# | Plasma viscosity (mPa·s) | 1.82 ± 0.23 | 1.88 ± 0.26 | 1.78 ± 0.21 | 1.42 ± 0.23*# | HCT (%) | 49.76 ± 4.80 | 47.64 ± 4.95 | 48.53 ± 5.30 | 47.61 ± 4.77 | Index of RBC deformation | 0.51 ± 0.01 | 0.50 ± 0.01 | 0.51 ± 0.07 | 0.59 ± 0.03* | Index of RBC aggregation | 1.21 ± 0.16 | 1.36 ± 0.19 | 1.38 ± 0.19 | 1.21 ± 0.16* |
|
|
Data are expressed as mean ± S.D., , compared with the pretreatment, , compared with control group.
|